Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.24 USD | +0.41% | -3.31% | +31.30% |
Evolution of the average Target Price on Agios Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Agios Pharmaceuticals, Inc.
RBC Capital Markets | |
Goldman Sachs | |
JPMorgan Chase | |
Piper Sandler | |
SVB Securities LLC | |
HC Wainwright | |
SVB Leerink | |
Canaccord Genuity | |
BofA Securities | |
Raymond James | |
Barclays | |
J.P. Morgan Chase |
EPS Revisions
- Stock
- Equities
- Stock Agios Pharmaceuticals, Inc. - Nasdaq
- Consensus Agios Pharmaceuticals, Inc.